Connect with us
Facing declining biotech financing and competitiveness, the European Commission has proposed the Biotech Act to boost investment, streamline regulation, and expand production. With Europe lagging behind...
A blood test detecting tumor DNA may personalize treatment for colorectal cancer patients with liver metastases after surgery. The GALAXY study shows patients with detectable DNA...
Karyopharm Therapeutics is a US biotechnology company focused on developing innovative cancer and serious disease therapies. Its value depends heavily on clinical trial success, regulatory approvals,...
Abivax shares surged nearly 36% after positive updated trial results for its ulcerative colitis drug obefazimod reassured investors following earlier safety concerns. New data showed strong...
Eli Lilly stock hit a record high, surpassing $1 trillion market value after strong product demand. Shares surged over 7%, entering price discovery with bullish RSI...
Gilead’s upcoming development plan for Assembly Biosciences’ HSV drugs could reshape the herpes market. ABI-5366 and ABI-1179 have shown strong antiviral results and may form a...
Galicia has approved its Biotechnology Strategy 2026–2030, mobilizing €805 million to boost competitiveness. The plan prioritizes health, agri-food, and advanced technologies, including the 1HealthAI hub. It...
Biotechnology company Graph Therapeutics raised 5 million dollars in a funding round led by Daphni, with support from existing investors. Including grants from Austrian agencies, total...
Gene therapies are transforming rare disease treatment, enabling normal lives for some patients. However, only about 6% of 7,000 rare diseases have treatments. Advances show curative...
Bavaria’s biotech sector grew in 2025, with companies rising 1.5% to 548 and funding exceeding €930 million. Startups surged, with 26 new firms. Employment reached 59,000....
 |
|
 |  |
 |
|